We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
51
Weyerhaeuser
WY
$18.5B
$5.92M 0.62%
162,302
+700
+0.4% +$25.6K
TFC icon
52
Truist Financial
TFC
$64.2B
$5.56M 0.59%
110,161
-300
-0.3% -$15.9K
DHR icon
53
Danaher
DHR
$143B
$5.26M 0.56%
60,158
+2,188
+4% +$195K
COST icon
54
Costco
COST
$419B
$5.13M 0.54%
24,548
+175
+0.7% +$34.6K
MMM icon
55
3M
MMM
$94.5B
$5.12M 0.54%
31,114
-825
-3% -$141K
BRK.A icon
56
Berkshire Hathaway Class A
BRK.A
$1.12T
$5.08M 0.54%
18
– –
CFR icon
57
Cullen/Frost Bankers
CFR
$10.2B
$5.01M 0.53%
46,254
-550
-1% -$62.1K
ADP icon
58
Automatic Data Processing
ADP
$107B
$4.92M 0.52%
36,698
-305
-0.8% -$38.7K
BMY icon
59
Bristol-Myers Squibb
BMY
$131B
$4.9M 0.52%
88,525
-5,398
-6% -$292K
EPD icon
60
Enterprise Products Partners
EPD
$81.9B
$4.69M 0.5%
169,643
+16,628
+11% +$455K
RDS.B
61
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$4.69M 0.5%
64,603
+31,375
+94% +$2.26M
UPS icon
62
United Parcel Service
UPS
$89.2B
$4.67M 0.49%
43,924
-9,675
-18% -$1.09M
T icon
63
AT&T
T
$163B
$4.54M 0.48%
187,354
-25,851
-12% -$649K
CRM icon
64
Salesforce
CRM
$157B
$4.35M 0.46%
31,886
+3,785
+13% +$483K
ABT icon
65
Abbott
ABT
$186B
$4.01M 0.42%
65,827
-500
-0.8% -$30.3K
MKL icon
66
Markel Group
MKL
$23.2B
$3.96M 0.42%
3,651
-15
-0.4% -$16.9K
GLW icon
67
Corning
GLW
$144B
$3.94M 0.42%
143,323
-4,200
-3% -$116K
VZ icon
68
Verizon
VZ
$195B
$3.85M 0.41%
76,449
+1,889
+3% +$91.4K
GE icon
69
GE Aerospace
GE
$386B
$3.83M 0.4%
58,707
-2,322
-4% -$155K
XLY icon
70
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$3.81M 0.4%
69,688
+12,610
+22% +$666K
ES icon
71
Eversource Energy
ES
$27.3B
$3.68M 0.39%
62,757
-3,180
-5% -$183K
HTLD icon
72
Heartland Express
HTLD
$952M
$3.58M 0.38%
192,930
-13,204
-6% -$244K
NKE icon
73
Nike
NKE
$61.9B
$3.49M 0.37%
43,775
-68
-0.2% -$4.79K
IP icon
74
International Paper
IP
$22.1B
$3.43M 0.36%
69,590
+29,964
+76% +$1.53M
KO icon
75
Coca-Cola
KO
$374B
$3.38M 0.36%
77,016
+174
+0.2% +$7.51K
1 2
3
4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.